BFM
ESPR

Boothbay Fund Management’s Esperion Therapeutics ESPR Stock Holding History

Boothbay Fund Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-205
Closed -$823K – 779
2019
Q1 		$823K Sell
205
-71
-26% -$3.19K 0.08% 270
2018
Q4 		$1.27M Sell
276
-424
-61% -$20.4K 0.19% 110
2018
Q3 		$3.11M Buy
700
+277
+65% +$12.7K 0.31% 69
2018
Q2 		$1.66M Buy
423
+234
+124% +$11.8K 0.14% 116
2018
Q1 		$1.37M Buy
+189
New +$13.9K 0.16% 130

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return